HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Monatepil

HCID 60810
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
103377-41-9
Standard SMILES
O=C(CCCN1CCN(c2ccc(F)cc2)CC1)NC1c2ccccc2CSc2ccccc21
InChIKey
WFNRNNUZFPVBSM-UHFFFAOYSA-N
Molecular formula
C28H30FN3OS
Average molar mass
475.6 g/mol
Monoisotopic mass
475.20936192

Overview

Monatepil is a dibenzothiepine.

Names & identifiers

Preferred name
Monatepil
IUPAC
N-(6,11-dihydrobenzo[c][1]benzothiepin-11-yl)-4-[4-(4-fluorophenyl)piperazin-1-yl]butanamide
English name
MONATEPIL
Molecular formula
C28H30FN3OS
Molecular weight
475.62

Names & synonyms

Monatepil103377-41-9monatepiloDTXSID3048811N4MMI0J7PWDTXCID60287371-Piperazinebutanamide, N-(6,11-dihydrodibenzo(b,E)thiepin-11-yl)-4-(4-fluorophenyl)monatepilum11-((4-(4-(4-fluorophenyl)-1-piperazinyl)butyryl)amino)-6,11-dihydrodibenzo(b,e)thiepin maleateRefChem:159485(+-)-N-(6,11-DIHYDRODIBENZO(B,E)THIEPIN-11-YL)-4-(P-FLUOROPHENYL)-1-PIPERAZINEBUTYRAMIDE132019-54-6
Show more names
N-(6,11-Dihydrodibenzo[b,e]thiepin-11-yl)-4-(4-(4-fluorophenyl)piperazin-1-yl)butanamideMonatepil [INN]N-(6,11-dihydrobenzo[c][1]benzothiepin-11-yl)-4-[4-(4-fluorophenyl)piperazin-1-yl]butanamideNCGC00183837-01(+/-)-N-(6,11-Dihydrodibenzo(b,E)thiepin-11-yl)-4-(p-fluorophenyl)-1-piperazinebutyramide1-Piperazinebutanamide, N-(6,11-dihydrodibenzo[b,e]thiepin-11-yl)-4-(4-fluorophenyl)-Monatepil [WHO-DD]N-(6,11-Dihydrodibenzo[b,e]thiepin-11-yl)-4-[4-(4-fluorophenyl)piperazin-1-yl]butanamide

Database identifiers

CAS
103377-41-9
PubChem CID
60810
DTXSID
DTXSID3048811
ChEMBL
CHEMBL172853
ChEBI
CHEBI:177480
UNII
N4MMI0J7PW
Nikkaji
J352.981I

Properties

Computed structural properties

XLogP
4.8
Topological polar surface area
60.9 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
5
Rotatable bonds
6
Heavy atoms
34
Formal charge
0
Complexity
650

Physicochemical properties

Melting point
194 · 194-194.5°
Boiling point
682 · 682.0±55.0 °C(Predicted)
Density
1.28 · 1.28±0.1 g/cm3(Predicted)
pka
14.71 · 14.71±0.20(Predicted)
FDA UNII
4 MMI0J7PW · N4MMI0J7PW
Comptox DTXSID
3048811 · DTXSID3048811

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 3 items

Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

A class of drugs that act by selective inhibition of calcium influx through cellular membranes.

Applications · 1 item

UsesN-(6,11-Dihydrodibenzo[b,e]thiepin-11-yl)-4-(4-(4-fluorophenyl)piperazin-1-yl)butanamide (CAS# 103377-41-9) is a useful research chemical compound used in the preparation of cyclopropylaminotriazolopyrimidine derivs. for use as P2Y12 receptor modulators.

Additional notes

DefinitionChEBI: Monatepil is a dibenzothiepine.

Related reactions

4 records
New reaction record
HRID 188134 reaction equation
HRID 188134As productTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
HRID 579748 reaction equation
HRID 579748As productuspto-grants-1988_06
HRID 579752 reaction equation
HRID 579752As productuspto-grants-1988_06
HRID 942504 reaction equation
HRID 942504As productValidation data from https://doi.org/10.1039/C8SC04228D

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes